Herbas VPB

Print
EN | LT
LT - Tricikliniai junginiai kaip priešvėžiniai agentai
EN - TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 471/04 (2006.01)
A61K 31/437 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3087071
(13) Kind of document T
(96) European patent application number 14824743.0
Date of filing the European patent application 2014-12-23
(97) Date of publication of the European application 2016-11-02
(45) Date of publication and mention of the grant of the patent 2018-09-05
(46) Date of publication of the claims translation 2018-11-12
PCT application
(86) Number PCT/US2014/072031
Date 2014-12-23
PCT application publication
(87) Number WO 2015/100282
Date 2015-07-02
Priority applications
(30) Number Date Country code
201361920500 P 2013-12-24 US
Inventors
(72)
NORRIS, Derek J., US
DELUCCA, George V., US
GAVAI, Ashvinikumar V., US
QUESNELLE, Claude A., US
GILL, Patrice, US
O`MALLEY, Daniel, US
VACCARO, Wayne, US
LEE, Francis Y., US
DEBENEDETTO, Mikkel V., US
DEGNAN, Andrew P., US
FANG, Haiquan, US
HILL, Matthew D., US
HUANG, Hong, US
SCHMITZ, William D., US
STARRETT, JR, John E., US
HAN, Wen-Ching, US
TOKARSKI, John S., US
MANDAL, Sunil Kumar, IN
Grantee
(73) Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Tricikliniai junginiai kaip priešvėžiniai agentai
  TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
Last renewal fee
Payment date Validity (years) Amount
2024-11-25 11 289.00 EUR
Next renewal fee
2025-12-23